ICCVAM Public Forum: July 2025

Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): advancing alternatives to animal testing

July 21, 1:00-4:00 p.m.
July 22, 9:00 a.m.-4:00 p.m.
Online

An agenda will be placed on this page by July 10 or as soon as it is available. Starting and ending times may be adjusted as the agenda is developed.

Registration will not be required to view the webinar. A link to view the webinar will be placed on this page shortly before the webinar begins.

To present a public statement at the webinar, please complete the registration form and email it to [email protected] by July 15.

ICCVAM’s goals include promotion of national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. To foster these partnerships ICCVAM holds annual public forums to share information and facilitate direct communication of ideas and suggestions from stakeholders.

This event will be presented as an online webinar. Representatives of ICCVAM member agencies will describe their agencies' activities both to advance new approaches to safety testing of chemicals and medical products and to reduce the amount of testing required. Participants will be able to ask clarifying or follow-up questions of the ICCVAM members about their presentations during the meeting. Instructions for submitting these questions will be provided to webcast viewers in announcements to be made at the beginning of each webinar session.

Submission of Public Statements

OMB#: 0925-0740; Expiration Date: 09/30/2025

Public reporting burden for this collection of information is estimated to average 3 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Privacy Act Statement:

First and last name, email address, and affiliation are primarily collected to register to make an oral statement or to submit a written public comment at the ICCVAM Public Forum. If you do not provide this information, you will not be able to register for oral comments. Providing telephone number and additional contact information is optional. Collection of this information is authorized under 5 U.S.C. 301, 305, 553; 21 U.S.C. 301 et seq.; 31 U.S.C. 1115(b)(6); 40 U.S.C. 11313; 42 U.S.C. 201 et seq.; 42 U.S.C. 203, 241, 289l-1; 44 U.S.C. 3101, 1505; Section 301 and 493 of the Public Health Service Act; E.O. 11583; and E.O. 13571. The Privacy Act System of Records Notices (SORNs) that covers collection of this information are 09-25-0156 Records of Participants in Programs and Respondents in Surveys Used to Evaluate Programs of the Public Health Service, HHS/PHS/NIH/OD and 09-90-1901 HHS Correspondence, Comment, Customer Service, and Contact List Records.

Members of the public are invited to present oral public statements on topics relevant to ICCVAM activities. Those wishing to provide public statements should notify organizers by email to [email protected] by Tuesday, July 15. The number and length of presentations may be limited based on available time. Submitters will be identified by their name and affiliation and/or sponsoring organization, if applicable. Persons submitting public statements and/or associated slides should include their name, affiliation (if any), and email in their submission. Those presenting oral public statements will be contacted to arrange the logistics of their presentations. View NTP guidelines for public statements.

Written statements on topics relevant to ICCVAM’s mission may be submitted to support an oral public statement or as standalone documents. These should be emailed to [email protected] by Tuesday, July 15. Public statements received by July 15 will be distributed to NICEATM and ICCVAM members before the meeting. Written public statements received after the deadline may be reviewed by NICEATM and ICCVAM at a future date. Materials submitted to accompany oral public statements or standalone written statements should include the submitters name, affiliation (if any), and email with the document and should adhere to NTP guidelines for public statements.